Investigating how RNA demethylation affects blood stem cell stability

The role of ALKBH5-mediated RNA demethylation in the maintenance of genomic stability in HSPCs

NIH-funded research University of Florida · NIH-11112366

This study is looking at how a specific enzyme helps keep blood stem cells healthy when they're under stress, which can happen in conditions like myelodysplastic syndromes (MDS), and it hopes to find new ways to protect these cells from turning into cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida NIH-funded
Lab location1 site (Gainesville, United States)
Project IDNIH-11112366 on NIH RePORTER

What this research studies

This research focuses on understanding the role of a specific enzyme, ALKBH5, in maintaining the stability of blood stem cells under oxidative stress, which is often linked to blood disorders like myelodysplastic syndromes (MDS). By examining how reactive oxygen species (ROS) impact RNA methylation and contribute to DNA damage, the study aims to uncover mechanisms that could prevent the transformation of healthy blood stem cells into cancerous cells. The approach involves analyzing the effects of ROS on RNA modifications and their subsequent influence on cell survival and regeneration. Patients may benefit from insights that could lead to new therapeutic strategies for blood-related diseases.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with myelodysplastic syndromes or other blood disorders characterized by compromised blood stem cell function.

Not a fit: Patients with non-hematological conditions or those whose blood disorders are not related to oxidative stress may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance the stability and function of blood stem cells, potentially improving outcomes for patients with blood disorders.

How similar studies have performed: Previous research has shown promising results in understanding the role of RNA modifications in cancer biology, suggesting that this approach may yield valuable insights.

Where this research is happening

Gainesville, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Blood Diseasesblood disorder
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.